Podcast Summary

Podcast: The Neuro Experience
Episode: 10 Things You Can Do to Prevent Alzheimer's | ft. Dr. Kellyann Niotis
Release Date: September 30, 2025
Host: Louisa Nicola (with Pursuit Network)
Guest: Dr. Kellyann Niotis, Preventive Neurologist

Overview

This episode dives deep into the complex landscape of Alzheimer’s disease: what it is, who is at risk, evolving biomarkers, the pivotal role of hormones and genetics, and – most notably – Dr. Niotis’ top evidence-based strategies to prevent its onset. Both Louisa and Dr. Niotis passionately advocate shifting the healthcare paradigm from late-stage intervention to actionable, preventive neurology, emphasizing that the earlier we intervene, the more effective it is in reducing the burden of neurodegenerative diseases.

Key Discussion Points & Insights

The Crisis of Alzheimer’s Disease

• Prevalence and Trajectory: Currently, 50 million people worldwide have Alzheimer’s; this is projected to triple by 2050, threatening to collapse healthcare systems ([00:19], Louisa).

  • “We're about to hit a really big epidemic of neurodegenerative diseases.” ([00:29], Dr. Niotis)

• Why Prevention is Crucial: Both the host and guest agree that prevention is the "most powerful tool we have" ([01:10], Louisa).

Understanding Alzheimer’s & Dementia

• Dementia as an Umbrella Term: Dementia covers neurodegenerative and other forms (e.g., depression-induced "pseudo-dementia"). Alzheimer’s is the most common ([02:40], Dr. Niotis).
• Dementia Affects the Young: Pathological changes can occur as early as one’s 30s, often before symptoms ([03:23], Dr. Niotis).
• Diagnosis: Alzheimer’s is a clinical-pathological diagnosis; both pathology and symptoms must be present ([04:19]–[05:36], Dr. Niotis & Louisa).

“If you die with Alzheimer’s disease pathology in your brain, but you lived a perfectly happy, cognitively normal life, did you have Alzheimer’s disease? No.”
— Dr. Kellyann Niotis, [04:50]

Genetics: The Controversies & Key Risk Genes

• Not Just Genetics: “It’s not a disease of genetics alone.” ([09:48], Louisa)
• Role of Family History: Provides clues but isn’t deterministic; family history is still essential in risk assessment ([12:10], Dr. Niotis).
• APOE:
  • APOE4 is the strongest genetic risk factor in sporadic Alzheimer’s ([14:04]–[24:39]).
  • One copy (E4) increases risk 2–4x, two copies (E4/E4) raise it 8–12x, but neither is deterministic.
  • Protective genotype (E2) exists, but comes with its own risks for other diseases.

“I’m always really hesitant to give exact numbers by which ApoE4 increases someone’s risk.”
— Dr. Kellyann Niotis, [22:17]

• Polygenic Nature: Over 70 genes implicated; risk is modified by gene-gene interactions ([24:41], Dr. Niotis).

Biomarkers & Early Detection

• Exploding Field: Blood tests can now detect pathology but aren’t fully validated for the asymptomatic or under-55 population ([25:11]–[27:32], Dr. Niotis).

“I don’t recommend people getting them tested on their own ... it has, and I’ve seen it firsthand, led to so much undue stress and anxiety”
— Dr. Kellyann Niotis, [25:23]

Sex Differences and Hormones

• Women Hit Hardest: Two-thirds of Alzheimer’s cases and caregiving fall on women; menopause, estrogen drop, and longevity are contributing factors ([28:45]–[29:46]).
• Hormone Replacement Therapy (HRT): Evidence is mounting for HRT’s benefits in cognition and possibly prevention, but robust, large-scale studies are still lacking ([31:03], Dr. Niotis).
• Other Sex Hormones (Testosterone, Progesterone): Likely undervalued; low testosterone and progesterone may be future risk markers, especially in women ([32:31], Louisa & Dr. Niotis).

Modifiable Risk Factors & The Case for Prevention

• 45% of Dementia May Be Preventable: Lifestyle (diet, exercise, vascular/metabolic health) plays a pivotal role ([33:36], Dr. Niotis).
• LDL, APOB, Statin Use:
  • High LDL/APOB are clear risk factors.
  • Statins can lower risk, despite public concern and fear-mongering ([35:23]–[40:11]).
• Blood Pressure: Both hypertension and very low blood pressure (in elderly) are risk factors; careful, personalized management is essential ([45:05]–[46:49]).
• Metabolic Health: Diabetes and insulin resistance are substantial risk factors, though the "Type 3 diabetes" label is debated ([56:46]–[57:38]).

Challenges in the Healthcare System

• Lack of Preventive Neurology Pathways: No formal clinics, training programs, or billing codes in most of the US ([50:39]–[53:16], Dr. Niotis).

“Right now, there’s no way for your insurance to cover family history of Alzheimer’s disease or APOE4. That’s not a diagnosis that reimburses hospitals...”
— Dr. Kellyann Niotis, [52:10]

• Society’s Reluctance: Both frustration and hope are voiced regarding slow system change – but optimism exists for the future ([54:09]–[55:22]).

Symptoms and Stages

• Long Prodromal Phase: Subtle changes (sense of smell, sleep, mood, early cognitive lapses) precede diagnosis by up to two decades ([58:11]–[59:52]).
• Differential Diagnosis is Tricky: Normal age-related "tip-of-the-tongue" vs. pathological symptoms can be hard to distinguish.

Mechanisms: Amyloid, Tau, Inflammation

• Amyloid & Tau: Both proteins are implicated, but there’s no single pathway; inflammation and individual biology play a role ([05:46]–[09:48], [60:23]–[64:40]).
• Clearance Pathways: Sleep and the glymphatic system help clear these toxins, as do microglia; new research (even lymphatic face massage in animal models) offers surprising avenues ([62:10]–[64:33]).

Diet & Nutrition

• No One Size Fits All: Keto vs. MIND vs. Mediterranean diets are discussed; sustainability and enjoyment trump dogmatism ([65:45]–[69:05]).
• Practical Advice: Mediterranean/MIND diets (fatty fish, berries, leafy greens, limited processed food) are easiest for most.
• Supplements: Not everyone needs them; omega-3s and creatine are most broadly endorsed, but only if bloodwork shows need ([81:02]–[82:46]).

Sensory, Physical & Cognitive Inputs

• Hearing, Vision, and Social Engagement: Hearing and recently, vision loss, have been added as modifiable risk factors ([72:38]–[73:36]).
• Cranial Nerve Testing: Used in risk workups; olfactory (smell) deficits can be an early prodrome ([72:00]–[72:38]).
• Cerebellum’s Role: Often neglected, it’s key in motor/cognitive integration, possibly with future implications ([74:12]–[75:28]).
• Exercise: Both aerobic and resistance training have profound direct and indirect effects (blood flow, anti-inflammatory myokines, fall prevention); recommended minimum is 2x/week ([75:50]–[77:29]).

Dr. Niotis’ 10 Top Strategies for Prevention

([78:25]–[80:48]: Timestamp for full rapid-fire list)

1. Know Your Personal Risk: Assess family history and, if appropriate, genetics.
2. Physical Activity: Regular, consistent exercise (both cardio and resistance).
3. Adopt a Mediterranean/MIND Diet: Balanced, rich in fish, berries, greens, and olive oil.
4. Check Hearing & Vision Regularly: Address deficits to keep the brain stimulated and active.
5. Monitor Cardiovascular Risk Factors: Cholesterol, blood pressure—don’t accept “normal” at face value.
6. Prioritize Metabolic Health: Screen for diabetes, insulin resistance.
7. Ensure Quality Sleep: Address sleep issues proactively.
8. Manage Blood Pressure: Optimal levels vary by age.
9. Mental/Social Engagement: Stay stimulated, connected, and happy—happiness itself is protective.
10. Supplements as Needed: Omega-3s and creatine only if bloodwork or diet indicates a deficiency.

“Making sure your metabolic health is under control ... getting enough sleep, making enough time for your sleep. And if you aren't sleeping, getting to the bottom of it. Is it stress, rumination, anxiety, pain, waking up to urinate?”
— Dr. Kellyann Niotis, [80:19]

Memorable Quotes & Moments

• On Prevention:
  “I truly, truly believe a large majority of these cases are preventable, if we just know how to find them and know what interventions to apply at the right time.”
  — Dr. Kellyann Niotis, [03:43]

• On the Fear around Statins:
  “There’s so much misinformation and there’s so much fear around statin use... it is mind-blowing.”
  — Dr. Kellyann Niotis, [38:34]

• On the Power of Prevention:
  “Not only is dementia preventable, but also those impacted early on can do things to change the trajectory… all hope is not lost.”
  — Dr. Kellyann Niotis, [87:01]

• Closing Reflection:
  “This is the only disease that robs you of who you are. Every single memory can be taken away … because of the choices you make.”
  — Louisa Nicola, [88:29]

Timestamps for Key Segments

• 00:19 – Alzheimer’s prevalence and future projections
• 03:23 – Young-onset diagnosis & prevention opportunity
• 14:04 – Understanding APOE and risk
• 25:23 – Blood-based biomarkers & self-testing warning
• 29:01 – Why are women at greater risk?
• 31:03 – Hormone replacement therapy: promise and limitations
• 35:23 – Lipids, APOE, and statin controversy
• 45:05 – Blood pressure nuances in prevention
• 50:24 – Why preventive neurology is still rare
• 56:46 – Is Alzheimer’s really “type 3 diabetes”?
• 65:45 – Diet wars: keto vs. Mediterranean/MIND
• 75:50 – Exercise and muscle as brain health insurance
• 78:25 – Dr. Niotis’ top 10 preventive strategies

Tone & Takeaway

The conversation is candid, passionate, and highly evidence-driven. Both Louisa and Dr. Niotis stress nuance: no one-size-fits-all solution, but a toolkit everyone can personalize—today—to meaningfully lower dementia risk. The target audience is empowered to take control and become proactive, not reactive, about their cognitive future.

Final Message (Dr. Niotis, [88:39]):
“Thank you for getting the message out there that preventive neurology exists, and it’s going to grow… In our lifetime, we’re going to see it as a huge, huge part of medical care.”